INSM Q2 2022 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65M+43.8% YoY

Gross Profit

$49M74.9% margin

Operating Income

-$88M-135.4% margin

Net Income

-$96M-146.6% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+22.8%

Cash Flow

Operating Cash Flow

-$102M

Free Cash Flow

-$105M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$1.0B

Stockholders' Equity

$44M

Cash & Equivalents

$416M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65M	$45M	+43.8%
Gross Profit	$49M	$35M	+41.4%
Operating Income	-$88M	-$89M	+0.3%
Net Income	-$96M	-$117M	+18.5%

Geographic Segments

UNITED STATES

$47M72%

JAPAN

$16M24%

Europe And The Rest Of The World

$2M3%